We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Hepregen Announces Appointment of Dr. Michael Holsapple

News   Aug 07, 2013

 
Hepregen Announces Appointment of Dr. Michael Holsapple
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine Reduces Incidence of Heartbeat Condition in Newborns

News

Researchers show that giving the antimalarial drug hydroxychloroquine to pregnant women who previously had a child affected by congenital heart block reduced the likelihood that the condition recurred in a subsequent pregnancy by 50%.

READ MORE

Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

News

Critically ill COVID-19 patients who received a single dose of intravenous tocilizumab were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to new research conducted by University of Michigan scientists.

READ MORE

Team Synthesizes Safer Nonaddictive Analgesics

News

A team has discovered a new class of drugs, capable of relieving pain and reducing fever without the danger of addiction or damage to the liver or kidneys.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE